RHÖN-KLINIKUM Aktiengesellschaft (ETR:RHK)
Germany flag Germany · Delayed Price · Currency is EUR
12.20
-0.10 (-0.81%)
At close: Mar 27, 2026

ETR:RHK Income Statement

Millions EUR. Fiscal year is Jan - Dec.
Fiscal Year
FY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Operating Revenue
1,7051,5961,4641,4461,402
Other Revenue
266272.24270.75215.07189.2
1,9711,8681,7351,6611,591
Revenue Growth (YoY)
5.51%7.67%4.43%4.40%2.92%
Cost of Revenue
1,7711,6581,5321,4571,409
Gross Profit
199.25209.77202.88203.78182.63
Selling, General & Admin
4.14.94.84.33.8
Other Operating Expenses
90.6195.193.5998.6380.47
Operating Expenses
154.92162.62163.88172.47154.91
Operating Income
44.3447.153931.3127.72
Interest Expense
-3.21-3.44-3.69-4.1-3.2
Interest & Investment Income
7.2411.0710.521.30.5
Earnings From Equity Investments
0.10.110.020.080.09
Other Non Operating Income (Expenses)
1.61.22.182.041.2
EBT Excluding Unusual Items
50.0656.0948.0330.6326.31
Impairment of Goodwill
-4.8----
Gain (Loss) on Sale of Investments
-0.110.32---0.55
Gain (Loss) on Sale of Assets
-0.2-0.2-0.3-0.2-0.1
Other Unusual Items
---3.21.7
Pretax Income
44.9556.247.7333.6327.36
Income Tax Expense
8.67117.566.69-2.87
Earnings From Continuing Operations
36.2845.2140.1726.9430.23
Minority Interest in Earnings
-1.81-1.86-1.46-1.8-1.93
Net Income
34.4743.3538.7125.1428.3
Net Income to Common
34.4743.3538.7125.1428.3
Net Income Growth
-20.48%11.98%53.96%-11.14%1850.03%
Shares Outstanding (Basic)
6767676767
Shares Outstanding (Diluted)
6767676767
EPS (Basic)
0.510.650.580.380.42
EPS (Diluted)
0.510.650.580.380.42
EPS Growth
-20.48%11.98%53.96%-10.56%2000.00%
Free Cash Flow
-41.957.246.22.119.7
Free Cash Flow Per Share
-0.630.850.690.030.29
Dividend Per Share
0.2000.100-0.150-
Dividend Growth
100.00%----
Gross Margin
10.11%11.23%11.70%12.27%11.48%
Operating Margin
2.25%2.52%2.25%1.88%1.74%
Profit Margin
1.75%2.32%2.23%1.51%1.78%
Free Cash Flow Margin
-2.13%3.06%2.66%0.13%1.24%
EBITDA
101.04106.55101.597.6194.82
EBITDA Margin
5.13%5.70%5.85%5.88%5.96%
D&A For EBITDA
56.759.462.566.367.1
EBIT
44.3447.153931.3127.72
EBIT Margin
2.25%2.52%2.25%1.88%1.74%
Effective Tax Rate
19.28%19.57%15.84%19.89%-
Revenue as Reported
1,9721,8691,7361,6661,600
Updated Dec 31, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.